Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SOX9 expression predicts relapse of stage II colon cancer patients
Maiken Lise Marcker Espersen, Dorte Linnemann, Ib Jarle Christensen, et al.
Human Pathology (2016) Vol. 52, pp. 38-46
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer
Maribel Aguilar‐Medina, Mariana Avendaño-Félix, Erik Lizárraga-Verdugo, et al.
Journal of Oncology (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 90
SOX9: An emerging driving factor from cancer progression to drug resistance
Munmun Panda, Surya Kant Tripathi, Bijesh K. Biswal
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188517-188517
Closed Access | Times Cited: 73
Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis
Fausto Petrelli, Michele Ghidini, Mary Cabiddu, et al.
Anticancer Research (2019) Vol. 39, Iss. 12, pp. 6431-6441
Open Access | Times Cited: 68
An Enhancer-Driven Stem Cell–Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer
Xiaoyan Liang, Gina N. Duronio, Yaying Yang, et al.
Gastroenterology (2021) Vol. 162, Iss. 1, pp. 209-222
Open Access | Times Cited: 47
Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets
Jingmei Lin, Chia-Chen Chuang, Li Zuo
Oncotarget (2017) Vol. 8, Iss. 10, pp. 17328-17346
Open Access | Times Cited: 59
Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer
Pankaj Ahluwalia, Ashis K. Mondal, Chance Bloomer, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3818-3818
Open Access | Times Cited: 53
SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling
Corinne Prévostel, Cyrine Rammah-Bouazza, Hélène Trauchessec, et al.
Oncotarget (2016) Vol. 7, Iss. 50, pp. 82228-82243
Open Access | Times Cited: 50
SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer
Haijun Zhou, Yi Qin, Shunrong Ji, et al.
Oncogene (2017) Vol. 37, Iss. 7, pp. 912-923
Open Access | Times Cited: 44
The dose-dependent effect of SOX9 and its incidence in colorectal cancer
Corinne Prévostel, Philippe Blache
European Journal of Cancer (2017) Vol. 86, pp. 150-157
Closed Access | Times Cited: 41
Single-cell transcriptomic analysis of normal and pathological tissues from the same patient uncovers colon cancer progression
Ruifang Sun, Yang Yang, Wei‐Dong Lü, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Expression and Clinical Relevance of SOX9 in Gastric Cancer
Patrícia Mesquita, Cristina Freire, Nair Lopes, et al.
Disease Markers (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 23
Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9
Yanlai Sun, Zhen Cao, Junqi Shan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 20
SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance
Surya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh K. Biswal
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2541-2550
Closed Access | Times Cited: 12
High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma
Shuwei Chen, Huan Li, Xiyuan Li, et al.
Cancer Medicine (2020) Vol. 9, Iss. 12, pp. 4274-4289
Open Access | Times Cited: 12
Copy‐number intratumor heterogeneity increases the risk of relapse in chemotherapy‐naive stage II colon cancer
Sara Lahoz, Iván Archilla, Elena Asensio, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 1, pp. 68-81
Open Access | Times Cited: 8
Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma
Wencke Reineking, Ida E. Schauerte, Johannes Junginger, et al.
Veterinary Pathology (2022) Vol. 59, Iss. 3, pp. 415-426
Closed Access | Times Cited: 7
SOX9 has distinct roles in the formation and progression of different non‐small cell lung cancer histotypes
Jie Bao, Katja Maria Närhi, Ana Teodòsio, et al.
The Journal of Pathology (2021) Vol. 255, Iss. 1, pp. 16-29
Open Access | Times Cited: 7
Genetic variants of SOX9 contribute to susceptibility of gliomas among Chinese population
Liang Wang, Gang Li, Nan Liu, et al.
Oncotarget (2016) Vol. 7, Iss. 40, pp. 65916-65922
Open Access | Times Cited: 5
The prognostic value of polycomb group protein B‐cell‐specific moloney murine leukemia virus insertion site 1 in stage II colon cancer patients
Maiken Lise Marcker Espersen, Dorte Linnemann, Ib Jarle Christensen, et al.
Apmis (2016) Vol. 124, Iss. 7, pp. 541-546
Open Access | Times Cited: 4
SOX9 is associated with advanced T-stages of clinical stage II colon cancer in young Mexican patients
Erik Lizárraga-Verdugo, Tatiana Galicia-Carmona, Rosalío Ramos‐Payán, et al.
Oncology Letters (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 5
In�vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction
Yingcai Hong, Huaisheng Chen, Zhan-Peng Rao, et al.
Experimental and Therapeutic Medicine (2018)
Open Access | Times Cited: 3
Copy-number intratumor heterogeneity contributes to predict relapse in chemotherapy-naive stage II colon cancer
Sara Lahoz, Iván Archilla, Elena Asensio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Role of SOX9 in cancer stem cell regulation in lung cancer chemoresistance and particle-induced carcinogenesis
Maria A. Voronkova
(2019)
Open Access
The role of SOX9 in non-small cell lung cancer progression is histopathology-selective
Jie Bao, Katja Maria Närhi, Ana Teodòsio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Cancer stem cell marker-positive tumour nests in intrahepatic cholangiocarcinoma are related to epithelial type CD1a-positive dendritic cell infiltration and to high Sox9 expression
Aya Utsunomiya, Rintaro Ohe, Takanobu Kabasawa, et al.
Research Square (Research Square) (2020)
Open Access
Page 1 - Next Page

Scroll to top